Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The RAS/RAF/MAPK pathway is crucial in cell signaling and implicated in various cancers.
• Activating BRAF mutations are prevalent in melanomas and colorectal carcinomas, contributing to oncogenesis.
• Mismatch-repair-deficient (MSI) tumors, particularly colon cancers, suggest a role for the RAS/RAF pathway in their tumorigenesis.

Purpose of the Study:

• To investigate specific genetic alterations in BRAF-mutated versus wild-type BRAF colorectal tumors with mismatch repair deficiency.
• To determine if BRAF mutations correlate with particular clinicopathological features in these tumors.

Main Methods:

• Genotyping of colorectal tumors for mutations in BRAF, APC, KRAS2, AXIN2, and TP53.
• Analysis of the association between BRAF mutations, tumor location (proximal/distal), mismatch repair deficiency, and MLH1 hypermethylation.

Main Results:

• A significant association was found between BRAF mutations and proximal mismatch-repair-deficient colon tumors.
• MLH1 hypermethylation was also strongly associated with BRAF-mutated proximal tumors.
• Mutations in APC, KRAS2, AXIN2, and TP53 were not specifically associated with BRAF-mutated tumors.

Conclusions:

• Proximal and distal colorectal tumors with mismatch repair deficiency exhibit different genetic profiles.
• The RAS/RAF pathway's role in colorectal tumorigenesis is modulated by tumor location and MLH1 inactivation status.